Paper Details
- Home
- Paper Details
Common selective serotonin reuptake inhibitor side effects in older adults associated with genetic polymorphisms in the serotonin transporter and receptors: data from a randomized controlled trial.
Author: DixonDavid, DoréPeter M, GarfieldLauren D, KristjanssonSean D, LenzeEric J, LotrichFrancis E, NowotnyPetra, PollockBruce G
Original Abstract of the Article :
Antidepressant side effects are a significant public health issue, associated with poor adherence, premature treatment discontinuation, and, rarely, significant harm. Older adults assume the largest and most serious burden of medication side effects. We investigated the association between antidepre...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://pubmed.ncbi.nlm.nih.gov/24021217
データ提供:米国国立医学図書館(NLM)
Unveiling the Genetic Factors Influencing SSRI Side Effects in Older Adults
The use of antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs), has become increasingly common in recent years. However, understanding the potential side effects of these medications, especially in older adults, is crucial. This research investigates the relationship between genetic variations in the serotonin system and the occurrence of side effects associated with SSRI use in older adults. The study involved a randomized, placebo-controlled trial of escitalopram, a commonly prescribed SSRI, in anxious older adults. The authors analyzed the genetic makeup of the participants and meticulously documented any side effects they experienced. This study underscores the importance of considering individual genetic variations when prescribing antidepressants, particularly in older adults.
Personalized Medicine: A Tailored Approach to Treatment
The results of this study support the growing trend towards personalized medicine, which emphasizes the importance of tailoring treatment strategies to individual patient characteristics, including their genetic makeup. The researchers' findings highlight the potential for genetic testing to help predict the likelihood of experiencing side effects from certain medications, allowing clinicians to make more informed decisions about treatment options. By taking individual genetic variations into account, healthcare providers can potentially improve patient outcomes and minimize the risk of unwanted side effects.
Navigating SSRI Treatment: A Collaborative Approach
This research emphasizes the need for open communication and collaboration between healthcare professionals and patients when considering SSRI treatment, especially in older adults. By being aware of the potential genetic factors that could influence side effect profiles, both patients and clinicians can work together to make informed decisions about treatment options. It's important to remember that every individual responds to medications differently, and personalized approaches are crucial for achieving optimal outcomes.
Dr. Camel's Conclusion
This research is a reminder that we are all unique, even in the desert of human biology. Just like different species of camels thrive in diverse environments, our individual genetic makeup influences how we react to medications. This study encourages us to embrace a personalized approach to healthcare, tailoring treatments to the unique needs of each patient.
Date :
- Date Completed 2015-05-28
- Date Revised 2022-12-07
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.